Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis

Cited by (660)

Items 401–500 of 660

  1. A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT RCT
    Fiona Gaughran, Daniel R. Stahl, Anita K. Patel, Khalida Ismail, Shubulade M Smith, Kathryn Greenwood, Zerrin Atakan, Poonam Gardner-Sood, Dominic Stringer, David Hopkins et al. · 2020 · Programme Grants for Applied Research
  2. The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
    Lucie Bartova, Gernot Fugger, Markus Dold, Alexander Kautzky, Marleen Margret Mignon Swoboda, Dan Rujescu, Joseph Zohar, Daniel Souery, Julien Mendlewicz, Stuart Montgomery et al. · 2021 · The International Journal of Neuropsychopharmacology
  3. Metabolic adverse effects of antipsychotics: the state of the problem and management options
    Балашова Анастасия Владимировна, Мамлеева Диана Валерьевна, Lubov V. Machekhina, Е. N. Dudinskaya · 2023 · Obesity and metabolism
  4. Large-scale data reveal disparate associations between leisure time physical activity patterns and mental health
    Ying Zhou, Chenshuang Li, Wei Wang, Lieyun Ding · 2023 · Communications Medicine
  5. Effect of contributing factors on the incidence of non-communicable diseases among adults with common mental health disorders: a systematic review
    Zeina Jamal, Rebecca Horn, Alastair Ager · 2023 · Global Health Research
  6. Prevalence and patient characteristics associated with cardiovascular disease risk factor screening in UK primary care for people with severe mental illness: an electronic healthcare record study
    Naomi Launders, Caroline Jackson, Joseph Hayes, Ann Mary John, Robert J. Stewart, Matthew H. Iveson, Elvira Bramon, Bruce Guthrie, Stewart William Mercer, David Osborn · 2025 · BMJ Mental Health
  7. Connecting the dots: Understanding and addressing the metabolic impact of antipsychotic and antidepressant medications
    Susanne U. Miedlich, J. Steven Lamberti · 2025 · Annals of the New York Academy of Sciences
  8. Exploring the impact of metformin on the central nervous system and neurotransmission: A systematic review
    Aleksandra Maciejczyk, Kamilla Blecharz‐Klin · 2025 · Biomedicine & Pharmacotherapy
  9. The effect of disease onset chronology on mortality among patients with multimorbidity: A Danish nationwide register study
    Tora Grauers Willadsen, Volkert Siersma, Dagný Rós Nicolaisdóttir, Rasmus Køster‐Rasmussen, Susanne Dalsgaard Reventlow, Maarten Pieter Rozing · 2022 · Journal of Multimorbidity and Comorbidity
  10. Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naïve patients with schizophrenia
    Zheng Ma, Huixia Zhou, Dachun Chen, Dongmei Wang, Xiangyang Zhang · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  11. Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan
    Jacob S. Ballon, René S. Kahn, Christina Arevalo, Martin Dunbar, David McDonnell, Christoph U. Correll · 2024 · The Journal of Clinical Psychiatry
  12. Physical Activity and Exercise as a Treatment of Depression: Evidence and Neurobiological Mechanism
    Brendon Stubbs, Felipe Barreto Schuch · 2019 · Elsevier eBooks
  13. Interventions involving own treatment choice for people living with coexisting severe mental illness and type 1 or 2 diabetes: A scoping review
    Vicki Zabell, Sabrina Trappaud Rønne, Ditte Høgsgaard, Rikke Jørgensen, Peter Gæde, Sidse Arnfred · 2021 · Diabetic Medicine
  14. The prevalence and clinical characteristics of diabetes mellitus in Chinese inpatients with chronic schizophrenia: a multicenter cross-sectional study
    Yanni Wang, Lingyun Zeng, Lijuan Chen, Xin Zhou, Lijuan Huo, Tingwei Wang, Yongjie Zhou, Xiangyang Zhang · 2021 · PeerJ
  15. Analysis of the Impact of Environmental Perception on the Health Status of Middle-Aged and Older Adults: A Study Based on CFPS 2020 Data
    Tingyi Liu, Huake Liu, Shibing You · 2023 · International Journal of Environmental Research and Public Health
  16. Metformin for Overweight and Obese Children With Bipolar Spectrum Disorders Treated With Second-Generation Antipsychotics (MOBILITY): Protocol and Methodological Considerations for a Large Pragmatic Randomized Clinical Trial
    Jeffrey A. Welge, Christoph Ulrich Correll, Michael T. Sorter, Victor Fornari, Thomas J. Blom, Adam C. Carle, Bin Huang, Christina C. Klein, Melissa P. DelBello · 2023 · JAACAP Open
  17. Exercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression
    Yu Tao, Wenbin Luo, Yue Chen, Caiyu Chen, Shengnan Chen, Xiaoping Li, Ken Chen, Chunyu Zeng · 2023 · Clinical Science
  18. Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress
    Weijia Cai, Canye Li, Zuanjun Su, Jinming Cao, Zhicong Chen, Yitian Chen, Zhijun Guo, Jian Cai, Feng Xu · 2023 · PeerJ
  19. Şizofreni hastalarında fiziksel hastalık eş tanılarının değerlendirilmesi
    Betül Döngel Demirel, Mehmet Emin Demirkol, Lut Tamam · 2018 · Çukurova medical journal (Online)/Çukurova medical journal
  20. Effects of Exercise on Functional Recovery in Patients with Bipolar Depression: A Study Protocol for a Randomized Controlled Trial
    Fumito Hamada, Hikaru Hori, Hitoshi Iida, Hiroyuki Yokoyama, Hiroko Sugawara, Akito Hatanaka, Leo Gotoh, Muneaki Ogata, Hiroki Kumagai, Rika Yano et al. · 2023 · Metabolites
  21. Deep retinal layer microvasculature alterations in schizophrenia
    Samantha I. Fradkin, Deepthi Bannai, Paulo L. Lizano, Adriann Lai, Christen M. Crosta, Judy L. Thompson, Steven M. Silverstein · 2024 · Biomarkers in Neuropsychiatry
  22. Sedentary time elimination with periodic activity snacks (STEPS): protocol for a codesigned feasibility trial in people with severe mental illness
    Mike Trott, Urška Arnautovska, Nicole Korman, Justin James Chapman, Gabrielle Ritchie, Brendon Stubbs, Dan J. Siskind · 2025 · BMJ Open
  23. Hospitalisation for mental health disorders in Australians with type 1 or type 2 diabetes
    Dunya Tomic, Jedidiah I Morton, Agus Salim, Tim J R Lambert, Dianna J. Magliano, Jonathan E. Shaw · 2023 · Diabetes Research and Clinical Practice
  24. Physical and mental health status of former smokers and non‐smokers patients with bipolar disorder
    Bénédicte Nobile, Ophélia Godin, Sébastien Gard, Ludovic Samalin, Georges Brousse, Joséphine Loftus, V. Aubin, Raoul Belzeaux-R, Caroline Dubertret, Yann Le Strat et al. · 2023 · Acta Psychiatrica Scandinavica
  25. Characterization of Hip Fractures Among Adults With Schizophrenia in Ontario, Canada
    Hina Ansari, Susan Brenda Jaglal, Angela M. Cheung, Paul A. Kurdyak · 2023 · JAMA Network Open
  26. Association of accelerated aging with the incidence risk of Cardiometabolic diseases in people with severe mental illnesses: A prospective analysis in UK Biobank
    Chengcheng Zhang, Zhen Ling, Xiang Qin Lin, Yang Zhang, Ling Li, Songchun Yang, Yi Xiao, Minxue Shen, Shuiyuan Xiao · 2024 · Psychiatry Research
  27. Global research in schizophrenia and serotonin: a bibliometric analysis
    Gustavo Canul-Medina, Gael López-Pech, Francisco Javier Jiménez-Trejo · 2024 · Frontiers in Psychiatry
  28. The effects of aerobic exercise for depression: An umbrella review of systematic reviews and meta-analyses
    Che Chen, Shaohui Du, Qianfeng Shao, XiaoWei Fu, Jin Lin, Sheng Li Zhou, Yue Li · 2024 · Journal of Bodywork and Movement Therapies
  29. Nonlinear association between depressive symptoms and homeostasis model assessment of insulin resistance: a cross-sectional analysis in the American population
    Chunqi Jiang, Wei Wang, Yinuo Qu, Jun Wang, Xin Zhang · 2025 · Frontiers in Psychiatry
  30. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
    Eva Z. Reininghaus, Mirko Manchia, Nina Dalkner, Nina Bonkat, Alessio Squassina, Isabel Hodl, Eduard Vieta, Andreas Reif, Tomáš Hájek, Mikael Landén et al. · 2021 · European Neuropsychopharmacology
  31. Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China
    Feiyun Ouyang, Jun He, Xunjie Cheng, Wei Zhou, Shuiyuan Xiao, Junqun Fang · 2022 · Frontiers in Psychiatry
  32. Mendelian randomization shows depression increases the risk of type 2 diabetes
    Sungho Won, Sanghun Lee, Jeewon Lee, Sanghun Lee, Sohee Oh · 2023 · Frontiers in Genetics
  33. Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine- or Olanzapine-Treated, Prediabetic, Schizophrenia Patients
    Jakub Tomasik, Nitin Rustogi, Julie Rask Larsen, Michelle Iris Jakobsen, Camilla Kara Svensson, Louise Vedtofte, Mathilde S. L. Jakobsen, Hans Søe Riis Jespersen, Kamuran Koyuncu, Ole Schjerning et al. · 2020 · Schizophrenia Bulletin Open
  34. Peripheral metabolic state and immune system in first-episode psychosis – A gene expression study with a prospective one-year follow-up
    Outi Mantere, Kalevi Trontti, Jarno K. Honkanen, Iiris Hovatta, Jaakko Keinänen, Jaana Suvisaari · 2021 · Journal of Psychiatric Research
  35. Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics
    Kristen M. Ward, Kyle Jon Burghardt, A. Zarina Kraal, Andrew P. Jaeger, Larisa Yeomans, Cora E. McHugh, Alla Karnovsky, Kathleen A. Stringer, Vicki L. Ellingrod · 2021 · Frontiers in Psychiatry
  36. Risk factors for metabolic and cardiovascular disease in inpatients with severe mental illness
    Luca Lavagnino, Christopher I. Gurguis, Scott D. Lane · 2021 · Psychiatry Research
  37. The risk of developing cardiovascular disease in bipolar disorder. Clinical and social factors
    Sergey N Mosolov, Elizaveta Yu. Fedorova · 2021 · Terapevticheskii arkhiv
  38. Different social contexts of leisure-time physical activity: Does the association with depressive symptoms differ?
    André O. Werneck, Felipe Barreto Schuch, Rômulo Araújo Fernandes, Brendon Stubbs, Célia Landmann Szwarcwald, Danilo Rodrigues Pereira da Silva · 2021 · Mental health and physical activity
  39. Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
    Christoph Ulrich Correll, Andrew J. Cutler, François Laliberté, Guillaume Germain, Sean D. MacKnight, Julien Boudreau, Sally W. Wade, Nadia Azmi Nabulsi, Huy‐Binh Nguyen, Mousam Parikh · 2025 · Annals of General Psychiatry
  40. Application of machine learning models for predicting depression among older adults with non-communicable diseases in India
    Kanchan Yadav, Dechenla Tshering Bhutia · 2025 · Scientific Reports
  41. Mental health and kidney disease
    Joseph Chilcot, Clodagh Cogley, Claire Carswell, Joanna L. Hudson, Sharlene Anuska Greenwood, Shivani Sharma, Kate Bramham, Andrew J. Lunn, Ken Farrington · 2026 · Nature Reviews Nephrology
  42. Longitudinal factors associated with mortality in older patients with mood disorders
    Chang Chen, Hung‐Yu Chan, Ling‐Ling Yeh, Yi‐Ju Pan · 2020 · Journal of Affective Disorders
  43. Exercise for depression treatment. Exercise modalities and types
    V. V. Gultyaeva, Margarita I. Zinchenko, D. Yu. Uryumtsev, Sergey Georgievich Krivoshchekov, Lyubomir I. Aftanas · 2019 · S S Korsakov Journal of Neurology and Psychiatry
  44. Study protocol for the systematic review and meta-analyses of the association between schizophrenia and bone fragility
    Behnaz Azimi Manavi, Amanda L. Stuart, Julie Anne Pasco, Jason M. Hodge, Kayla B. Corney, Michael Berk, Lana J. Williams · 2020 · BMJ Open
  45. Trastorno bipolar
    M. Arrieta, P. Molero Santos · 2019 · Medicine - Programa de Formación Médica Continuada Acreditado
  46. A controlled open clinical trial of the positive effect of a physical intervention on quality of life in schizophrenia
    Viviane Batista Cristiano, Michele Fonseca Szortyka, Paulo Silva Belmonte-de-Abreu · 2023 · Frontiers in Psychiatry
  47. Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia
    Ling‐Ling Yeh, Wei‐Chen Lee, Kuei‐Hong Kuo, Yi‐Ju Pan · 2023 · Pharmaceuticals
  48. The impact of providing care for physical health in severe mental illness on informal carers: a qualitative study
    Dolly Sud, Eleanor Bradley, Jonathan Quetzal Tritter, Ian D. Maidment · 2024 · BMC Psychiatry
  49. ‘Join The Walk?’: Short-term and follow-up effects of a 10-week walking intervention in patients with a mental disorder
    Jari Vanroy, Jan Seghers, An Bogaerts, Anne I. Wijtzes, Filip Boen · 2017 · Mental health and physical activity
  50. Psychosocial factors associated with physical activity behavior among patients with psychosis
    Jenny T.M. Lee, Eunice Y.L. Law, Lincoln Lik Hang Lo, Jingxia Lin, Edwin Ho Ming Lee, Christy Lai Ming Hui, Catherine Shiu Yin Chong, Sherry Kit Wa Chan, William Tak-Lam Lo, Eric Yu Hai Chen · 2017 · Schizophrenia Research
  51. Evaluating correlations between physical activity, psychological mediators of physical activity, and negative symptoms in individuals living with psychosis and diabetes.
    Paul Filip Gorczynski, Davy Vancampfort, Hiren Patel · 2018 · Psychiatric Rehabilitation Journal
  52. Exercise Interventions in Secure and Forensic Services
    Brendon Stubbs, Simon Rosenbaum · 2018 · Elsevier eBooks
  53. Psychopharmakotherapie bei älteren Menschen mit schweren psychischen Erkrankungen
    Christian Lange‐Asschenfeldt · 2018 · Zeitschrift für Gerontologie und Geriatrie
  54. A national survey of psychiatrists’ attitudes towards the physical examination*
    Sarah F. Baillon, Jonathan Murray · 2019 · Journal of Mental Health
  55. A network analysis framework of genetic and nongenetic risks for type 2 diabetes
    Yuan Zhang, Shu Li, Zhi Cao, Yangyang Cheng, Chenjie Xu, Hongxi Yang, Li Sun, Hongxiao Jiao, Wang Ju, Weidong Li et al. · 2020 · Reviews in Endocrine and Metabolic Disorders
  56. Undiagnosed disease in decedents with and without schizophrenia: an autopsy-based case-control study
    Oscar Emil Puntervold, Line Kruckow, Jytte Banner · 2021 · Nordic Journal of Psychiatry
  57. A feasibility hybrid II randomised controlled trial of volunteer ‘Health Champions’ supporting people with serious mental illness manage their physical health: study protocol
    Julie Williams, Elliann Fairbairn, Ray McGrath, Ioannis Bakolis, Andy Healey, Ubong Akpan, Isabel Mdudu, Fiona Gaughran, Euan Sadler, Zarnie Khadjesari et al. · 2021 · Pilot and Feasibility Studies
  58. A Year Into the Pandemic: The Diversity of Experience Amongst People With Severe Mental Ill Health
    Emily Jane Peckham, Panagiotis Spanakis, Paul Heron, Suzanne Crosland, Gordon Johnston, Elizabeth Newbronner, Ruth Wadman, Lauren E. Walker, Simon M. Gilbody · 2022 · Frontiers in Psychiatry
  59. Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study
    Vasiliki Mamakou, Sophie Hackinger, Eleni Zengini, Evgenia I. Tsompanaki, Eirini Marouli, Ioannis Serafetinidis, Bram Peter Prins, Athina Karabela, Eirini Glezou, Lorraine Southam et al. · 2018 · BMC Psychiatry
  60. Thinking inside the box
    Jeroen Deenik · 2019
  61. Diagnostik und Früherkennung bipolarer Störungen
    Martin Schäfer, Christoph Ulrich Correll · 2020 · Der Nervenarzt
  62. Time trends of coronary procedures, guideline-based drugs and all-cause mortality following acute coronary syndrome in patients with bipolar disorder
    Line Philipsen, Nanna Würtz, Christoffer Polcwiartek, Kristian Hay Kragholm, Christian Tobias Torp-Pedersen, René Ernst Nielsen, Svend Eggert Jensen, Rubina Attar · 2022 · Nordic Journal of Psychiatry
  63. Health status and quality of life in comorbid physical multimorbidity and depression among adults aged ⩾50 years from low- and middle-income countries
    Mireia Félez-Nóbrega, Ai Koyanagi · 2023 · International Journal of Social Psychiatry
  64. Physical activity and mortality in the general population with and without major depression
    Vagner Deuel de Oliveira Tavares, Jeanne V.A. Williams, Vandad Sharifi‎, Andrew GM Bulloch, Gina Dimitropoulos, Nicole Leite Galvão Coelho, Scott Burton Patten · 2024 · Academia Mental Health and Well-Being
  65. Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study
    Keisuke Ueno, Daisuke Chujo, Nobuyuki Takahashi, Mitsuru Ohsugi, Kohjiro Ueki, Hiroshi Kajio · 2020 · Diabetes Therapy
  66. Serious Mental Illness Exacerbation Post-Bereavement: A Population-Based Study of Partners and Adult Children
    Djin Lyn Tay, Lau Caspar Thygesen, Elissa Kozlov, Katherine A. Ornstein · 2022 · Clinical Epidemiology
  67. Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring
    Weiyao Yin, Martina Persson, Sven Sandin · 2022 · Diabetes & Metabolism
  68. The financial situation before and after first-time psychiatric in-patient diagnosis of schizophrenia spectrum, bipolar, and major depressive disorder
    Marcus Eliason · 2023 · Economics & Human Biology
  69. Sex differences in the prevalence and clinical correlates of diabetes in Chinese patients with chronic schizophrenia
    Huiming Yan, Yanzhe Li, Shen Li, Chi Zhou, Shuochi Wei, Jie Li, Xiangyang Zhang · 2023 · Heliyon
  70. Diabetes Mellitus: An Unrecognized Complication in the Management of Patients With Mental Illness
    Diana Espinoza, Paola A Sanchez, Christine C. Junia · 2020 · Cureus
  71. The Impact of Smoking Cessation on Hospitalization and Psychiatric Medication Utilization among People with Serious Mental Illness
    Jennifer Kertes, Orit Stein-Reisner, Leon J. Grunhaus, Yehuda D. Neumark · 2021 · Substance Use & Misuse
  72. Investigating the effect of glycaemic traits on the risk of psychiatric illness using Mendelian randomisation
    Danielle M. Adams, William R. Reay, Michael P. Geaghan, Murray J. Cairns · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Revisiting diabetes risk of olanzapine versus aripiprazole in serious mental illness care
    Denis M. Agniel, Sharon‐Lise T. Normand, John W. Newcomer, Katya Zelevinsky, Jason Poulos, Jeannette Tsuei, Marcela V. Horvitz-Lennon · 2024 · BJPsych Open
  74. A multidisciplinary weight management intervention for adults with severe mental illness in forensic psychiatric inpatient services (Motiv8): a single blind cluster-randomised wait-list controlled feasibility trial
    Rebekah Carney, Heather Law, Hany El-Metaal, Mark Hann, Gemma Shields, Siobhan Savage, Ingrid Small, Richard Jones, David Shiers, Gillian Macafee et al. · 2024 · Frontiers in Psychiatry
  75. Quantifying consultations to medical specialties during psychiatric inpatient admissions in a Queensland tertiary hospital
    Carissa Holland, Pamela Hudson-Jessop · 2022 · Australasian Psychiatry
  76. Relationship between Environmental Conditions and Utilisation of Community-Based Mental Health Care: A Comparative Study before and during the COVID-19 Pandemic in Italy
    Eleonora Prina, Federico Tedeschi, Antonio Lasalvia, Damiano Salazzari, Sara Latini, Laura Rabbi, Federica Marando, Elaine van Rijn, Jan Wollgast, Enrico Pisoni et al. · 2024 · International Journal of Environmental Research and Public Health
  77. Health Perceptions and Risk of Metabolic Syndrome and Diabetes in Psychiatric Patients
    Şenay Öztürk, Elvan Emine Ata, Merve Sarıtaş · 2024 · Journal of Psychiatric and Mental Health Nursing
  78. Psychiatric factors predict type 2 diabetes mellitus in US Veterans
    Lora Pless, Chantele Mitchell-Miland, Yeon‐Jung Seo, Charles B. Bennett, Zachary Freyberg, Gretchen L. Haas · 2025 · Schizophrenia
  79. Evaluation of retinal layer thickness in patients with bipolar disorder, their relatives, and healthy controls using optical coherence tomography
    Erbil Seven, Faruk Kurhan · 2025 · World Journal of Biological Psychiatry
  80. Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP Biotypes
    Liisi Promet, Shashwath A. Meda, Ney Alliey‐Rodriguez, Brett A. Clementz, Elliott S. Gershon, Scot Kristian Hill, Elena I Ivleva, Sarah Keedy, Matcheri S. Keshavan, Jennifer E. McDowell et al. · 2025 · Schizophrenia Bulletin
  81. Sedentary Behavior and Quality of Life in People with Psychotic Disorders from a Low Income Country: A Study from Uganda
    Davy Vancampfort, Michel Probst, Simon Rosenbaum, Philip B. Ward, Tine Van Damme, James Mugisha · 2018 · Community Mental Health Journal
  82. Kronik Ruhsal Hastalığı Olan Bireylerde Diyabet Yönetimi ve Psikiyatri Hemşiresinin Rolü
    Sevecen Çelik İnce, Neslihan Partlak Günüşen · 2020 · Etkili Hemşirelik Dergisi
  83. Prevalence and clinical correlates of impaired glucose tolerance in first‐episode versus chronic patients with schizophrenia
    Shen Li, Dachun Chen, Meihong Xiu, Jie Li, Xiangyang Zhang · 2021 · Early Intervention in Psychiatry
  84. Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time‐trend analysis from 2004 to 2021
    Charlotte Greene, Luke A. K. Blackbourn, Stuart J. McGurnaghan, Stewart William Mercer, Daniel J. Smıth, Sarah H. Wild, Honghan Wu, Caroline Jackson · 2024 · British Journal of Clinical Pharmacology
  85. Examining methods, messengers and behavioural theories to disseminate physical activity information to individuals with a diagnosis of schizophrenia: a scoping review
    Paul Filip Gorczynski, Matthew Sitch, Guy Faulkner · 2017 · Journal of Mental Health
  86. Depressive symptom profiles and glucose tolerance status
    Pasi J Eskola, JUHA P. AUVINEN, Jari J. Jokelainen, Timo Liukkonen, Sylvain P Sebert, Aimo Ruokonen, Katri S. Puukka, Markku Timonen, Sirkka M Keinanen-Kiukaanniemi · 2017 · World Psychiatry
  87. Well-being, physical and mental health: part 1
    Sheila Hardy, Bob Price · 2018 · Mental Health Practice
  88. Using the Minnesota Multiphasic Personality Inventory-2-Restructured Form Cutoffs to Predict Lack of Pre-surgical Exercise
    Brooke R. Fusco, Ryan J. Marek, Anthony M. Tarescavage, Yossef S. Ben‐Porath, Leslie J. Heinberg · 2018 · Journal of Clinical Psychology in Medical Settings
  89. Oral health inequality in people with severe mental illness: a cross-sectional study using National Health and Nutrition Examination Survey 1999-2016
    Jing Xin Kang, Jianhua Wu, Vishal R. Aggarwal, David Shiers, Tim Doran, Jasper E. Palmier‐Claus · 2021 · medRxiv
  90. Inflammatory markers, somatic complaints, use of medication and health care in 11-year-old children at familial high risk of schizophrenia or bipolar disorder compared with population-based controls. The Danish High Risk and Resilience Study - via 11
    Anne Søndergaard, Maja Gregersen, Martin Wilms, Julie Marie Brandt, Carsten Rygaard Hjorthøj, Jessica Ohland, Sinnika Birkehøj Rohd, Nicoline Hemager, Anna Krogh Andreassen, Christina Bruun Knudsen et al. · 2024 · Nordic Journal of Psychiatry
  91. Clinical Characterisation of the Co-Occurrence of Mental and Physical Disorders
    Richard I. G. Holt · 2025 · Springer eBooks
  92. The DIAMONDS intervention for type 2 diabetes for people with severe mental illness: findings from a single-group feasibility study
    Jennifer Valeska Elli Brown, Claire Carswell, Danielle Podmore, Imogen Featherstone, Sarah Louise Alderson, Jan R. Böhnke, Tim Doran, Michelle Hadjiconstantinou, Catherine Elizabeth Hewitt, Richard I. G. Holt et al. · 2025 · Frontiers in Health Services
  93. Social and environmental disparities in mental health benefits from active transport in the UK: a causal machine learning analysis
    Shujuan Chen, Yue Li, Ying Jin · 2025 · Transportation Research Part A Policy and Practice
  94. Prevalence and outcomes of co-occurring psychiatric and endocrine, metabolic, and nutritional disorders: An atlas based on umbrella review of 254,154,533 records
    Michele Fornaro, Chiara Di Lorenzo, Luca Steardo, Nicola Veronese, Brendon Stubbs, Davy Vancampfort, Dan J. Siskind, Marco Solmi · 2026 · European Neuropsychopharmacology
  95. Sedentary Behavior and Physical Activity in Individuals With Bipolar Disorder: An Evidence Synthesis and Position Statement From the ISBD Nutrition and Exercise Task Force (NExT)
    Beny Lafer, Lucas Melo Neves, Davy Vancampfort, Brendon Stubbs, Ana Gonzalez-Pinto, Andrew Alan Nierenberg, Andrew T Olagunju, Benjamin I. Goldstein, Eduard Vieta, Elena Koning et al. · 2026 · Bipolar Disorders
  96. Performance in Practice: Practice Assessment Tool for the Care of Patients With Schizophrenia
    Laura J. Fochtmann, Jennifer Medicus, Seung-Hee Hong · 2020 · FOCUS The Journal of Lifelong Learning in Psychiatry
  97. Adherence to smoking cessation guidelines (5As) by psychiatrists and primary care physicians for persons with serious mental illness
    Jennifer Kertes, Orit Stein-Reisner, Leon J. Grunhaus, Yehuda D. Neumark · 2021 · Journal of Addictive Diseases
  98. Diabetes care among individuals with and without schizophrenia in three Canadian provinces: A retrospective cohort study
    Braden Gregory O’Neill, Abban Yusuf, Paul A. Kurdyak, Tara Kiran, Frank Sullivan, Tao Chen, Sumeet Kalia, David Eisen, Elizabeth L. Anderson, Peter L. Selby et al. · 2023 · General Hospital Psychiatry
  99. Serious Mental Illness, Glycemic Control, and Neighborhood Factors within an Urban Diabetes Cohort
    Esti Iturralde, Anna D. Rubinsky, Kim Hanh Nguyen, Chelsie Anderson, Courtney Rees Lyles, Christina V. Mangurian · 2023 · Schizophrenia Bulletin
  100. Factor structure of psychosis screening questionnaire in Ugandan adults
    Claire Kwagala, Amantia Ametaj, Hannah Hayoung Kim, Joseph Kyebuzibwa, Okura Rogers, Anne Stevenson, Bizu Gelaye, Dickens Howard Akena · 2024 · BMC Psychiatry